NPR logo

How 2 Children With Leukemia Helped Transform Its Treatment

  • Download
  • <iframe src="https://www.npr.org/player/embed/394897664/395001665" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
How 2 Children With Leukemia Helped Transform Its Treatment

Living Cancer

How 2 Children With Leukemia Helped Transform Its Treatment

How 2 Children With Leukemia Helped Transform Its Treatment

  • Download
  • <iframe src="https://www.npr.org/player/embed/394897664/395001665" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Both James Eversull (left) and Pat Patchell were treated with experimental chemotherapy and radiation for leukemia as children in the 1960s. Together, they're now some of the country's oldest leukemia survivors.. Courtesy of James Eversull; Courtesy of Pat Patchell hide caption

toggle caption
Courtesy of James Eversull; Courtesy of Pat Patchell

Both James Eversull (left) and Pat Patchell were treated with experimental chemotherapy and radiation for leukemia as children in the 1960s. Together, they're now some of the country's oldest leukemia survivors..

Courtesy of James Eversull; Courtesy of Pat Patchell

When children are diagnosed with acute lymphoblastic leukemia now, they have more than a 90 percent chance of survival.

But when James Eversull was told he had leukemia in 1964, there wasn't much hope.

He was just 18 months old when his parents discovered what was wrong.

He says he remembers as an older toddler overhearing his family and doctors discussing his illness. "My nickname was 'Jimmy,' and they would say 'Jimmy with cancer, Jimmy with cancer,' " he said. "Because you say cancer back in the 1960s, and they think if you touch them you're going to catch it."

Eversull's parents were determined to help him. The family drove almost 400 miles from their home in Louisiana to St. Jude Children's Research Hospital in Memphis, Tenn.

St. Jude was named after the patron saint of lost causes for a reason.

"These children were often turned away," said Dr. Donald Pinkel about his years as a young doctor in the 1950s. He went on to become the first medical director at St. Jude. "A lot of physicians just didn't want to handle this situation — it was so sad."

  • Dr Donald Pinkel, first medical director at St. Jude, led the hospital's leukemia research trials in the 1960s.
    Hide caption
    Dr Donald Pinkel, first medical director at St. Jude, led the hospital's leukemia research trials in the 1960s.
    Courtesy of St. Jude Children's Research Hospital
  • Dr. Donald Pinkel meets with a family at St. Jude.
    Hide caption
    Dr. Donald Pinkel meets with a family at St. Jude.
    Courtesy of St. Jude Children's Research Hospital
  • St. Jude was founded by performer Danny Thomas in 1960. St. Jude is the patron saint of hope and impossible causes.
    Hide caption
    St. Jude was founded by performer Danny Thomas in 1960. St. Jude is the patron saint of hope and impossible causes.
    Courtesy of St. Jude Children's Research Hospital
  • Danny Thomas looks through a microscope as Dr. Donald Pinkel stands just behind him.
    Hide caption
    Danny Thomas looks through a microscope as Dr. Donald Pinkel stands just behind him.
    Courtesy of St. Jude Children's Research Hospital

1 of 4

View slideshow i

Eversull's mother, Brenda, who was 19 years old at the time, said the hospital was not an encouraging sight. "All during that day, I kept seeing kids die," she said.

She was scared, but she didn't think Jimmy looked as sick as the other children she saw in the hallways. "Tubes coming out here and there ... it was horrible. I just wanted to take my son and go home."

But the physicians at St. Jude were trying something new: a chemotherapy drug cocktail paired with radiation. They called it "Total Therapy III." It's a variation of what most acute lymphoblastic leukemia patients still get today. But patients like Eversull, acting as guinea pigs, were among the first ones to try it.

A few years ago, cancer survivor James Eversull was told that he needed to lose weight and exercise. He took his doctor's orders seriously and today is an avid marathon runner. Amanda Aronczyk/WNYC hide caption

toggle caption
Amanda Aronczyk/WNYC

A few years ago, cancer survivor James Eversull was told that he needed to lose weight and exercise. He took his doctor's orders seriously and today is an avid marathon runner.

Amanda Aronczyk/WNYC

"You say experimental, you know, and I'm thinking, oh my God, like Young Frankenstein or Dr. Jekyll and Mr. Hyde," Eversull said. "You're giving me something and you don't even know what it's going to do?"

This was an era before experiments on humans were closely regulated. Pinkel had an advisory board for difficult ethical questions. It wasn't as though the doctors had no oversight.

But Pinkel and his colleagues thought experimenting with toxic treatments was worth the risk of making the kids sicker. They didn't know if the kids would survive otherwise.

"It was very difficult," Pinkel said. "You have to be very careful in these early phases because you could shove them over the brink with your therapy."

Chemotherapy was showing promise for some young patients, but the challenge was maintaining remission.

Pat Patchell was diagnosed with cancer when he was 11. At age 62, he is one the country's oldest survivors of childhood leukemia. Courtesy of St. Jude Children's Research Hospital hide caption

toggle caption
Courtesy of St. Jude Children's Research Hospital

Pat Patchell was diagnosed with cancer when he was 11. At age 62, he is one the country's oldest survivors of childhood leukemia.

Courtesy of St. Jude Children's Research Hospital

What distinguished Total Therapy III from earlier protocols was the use of radiation to the brain to avoid relapses. The treatment would result in a lasting remission for many of the children, but the doctors feared cognitive problems later in life. The challenge became deciding when to take the children off the treatment.

"I do remember one doctor said, 'You stay with the winning horse,' " said Pat Patchell, 62, one of St. Jude's oldest leukemia survivors.

"I think it was a pretty big decision on their part," Patchell said. "It was very much unknown territory. That's why they kept an eye on me for so long. I was into my 30s before I stopped coming back every year."

Find other stories in the Living Cancer series at WNYC.org. WNYC hide caption

toggle caption
WNYC

Both Patchell and Eversull still return to St. Jude for periodic checkups. Of the 26 children who started Total Therapy III treatments in the early 1960s, only five made it to adulthood. Three are alive today.

Still, the research was a crucial step in developing a treatment for acute lymphoblastic leukemia. "Total III was the breakthrough," said Pinkel. "That's where we got cures and that's where we have patients today who are up there in age now and are alive and well."

When these men were patients the chance of surviving was less than 5 percent, but a decade later, thanks in part to this work, oncologists could start to say there was a cure for acute lymphoblastic leukemia.

Our series is produced with member station WNYC, and with Ken Burns Presents: Cancer: The Emperor of All Maladies, which will air on PBS starting March 30. Check your local listings for broadcast times.

Support WNYC Radio

Stories like these are made possible by contributions from readers and listeners like you.